Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001829126-23-004386
Filing Date
2023-06-23
Accepted
2023-06-23 17:28:40
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-1 titanpharma_s1.htm S-1 485308
2 EXHIBIT 23.1 titanpharma_ex23-1.htm EX-23.1 4975
3 EXHIBIT 107 titanpharma_ex107.htm EX-FILING FEES 24068
5 GRAPHIC ex23-1_001.jpg GRAPHIC 43100
6 GRAPHIC ex23-1_002.jpg GRAPHIC 27548
7 GRAPHIC ex23-1_003.jpg GRAPHIC 59438
8 GRAPHIC img_001.jpg GRAPHIC 6731
9 GRAPHIC cover_001.jpg GRAPHIC 28888
10 GRAPHIC cover_002.jpg GRAPHIC 15129
  Complete submission text file 0001829126-23-004386.txt   763161
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-272910 | Film No.: 231038795
SIC: 2836 Biological Products, (No Diagnostic Substances)